Literature DB >> 6622018

Laser trabeculoplasty and the glaucomas.

M F Lieberman, H D Hoskins, J Hetherington.   

Abstract

A standard 100-spot laser trabeculoplasty was applied to 137 eyes of 109 presurgical patients with a variety of primary, secondary, and postsurgical glaucomas. Average follow-up was 15.3 months. Laser therapy was most successful in eyes without prior surgery (chronic open-angle glaucoma (COAG), pseudoexfoliation, pigmentary dispersion) or with only one prior operation (iridectomy, trabeculectomy, or intracapsular cataract extraction). The mean range for pressure reduction was 6 to 12 mmHg. Failures were frequently seen in eyes with angle recession, uveitis, or more than one operation. Visual field deterioration was seen in 11% of successful COAG eyes. Asymmetric responses in bilaterally treated COAG patients were seen half the time. A drift downward of 5 mmHg or more at six months after laser reversed itself by 12 months in approximately one out of eight eyes from various categories.

Entities:  

Mesh:

Year:  1983        PMID: 6622018     DOI: 10.1016/s0161-6420(83)34486-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

Review 1.  A unification hypothesis of pigment dispersion syndrome.

Authors:  R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1996

2.  Two Japanese cases of pigmentary glaucoma followed for 15 and 16 years following laser peripheral iridotomy.

Authors:  Akira Sawada; Hiroki Yamada; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2012-01-17       Impact factor: 2.447

3.  Laser trabeculoplasty and decay effects in glaucoma patients.

Authors:  A I Fink; A J Jordan
Journal:  J R Soc Med       Date:  1984-02       Impact factor: 5.344

4.  Long-term follow-up of laser trabeculoplasty.

Authors:  G R Eendebak; T N Boen-Tan; P D Bezemer
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

5.  Late failures of trabeculoplasty.

Authors:  F Moulin; J Haut; J Abi Rached
Journal:  Int Ophthalmol       Date:  1987-02       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.